| Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship DW Kindelberger, Y Lee, A Miron, MS Hirsch, C Feltmate, F Medeiros, ... The American journal of surgical pathology 31 (2), 161-169, 2007 | 1483 | 2007 |
| Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer DP Silver, AL Richardson, AC Eklund, ZC Wang, Z Szallasi, Q Li, N Juul, ... Journal of clinical oncology 28 (7), 1145-1153, 2010 | 1292 | 2010 |
| A candidate precursor to serous carcinoma that originates in the distal fallopian tube Y Lee, A Miron, R Drapkin, MR Nucci, F Medeiros, A Saleemuddin, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007 | 1105 | 2007 |
| X chromosomal abnormalities in basal-like human breast cancer AL Richardson, ZC Wang, A De Nicolo, X Lu, M Brown, A Miron, X Liao, ... Cancer cell 9 (2), 121-132, 2006 | 967 | 2006 |
| Distinct roles for E2F proteins in cell growth control and apoptosis J DeGregori, G Leone, A Miron, L Jakoi, JR Nevins Proceedings of the National Academy of Sciences 94 (14), 7245-7250, 1997 | 914 | 1997 |
| The distal fallopian tube: a new model for pelvic serous carcinogenesis CP Crum, R Drapkin, A Miron, TA Ince, M Muto, DW Kindelberger, Y Lee Current Opinion in Obstetrics and Gynecology 19 (1), 3-9, 2007 | 625 | 2007 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 596 | 2015 |
| A recurrent mutation in PALB2 in Finnish cancer families H Erkko, B Xia, J Nikkilä, J Schleutker, K Syrjäkoski, A Mannermaa, ... Nature 446 (7133), 316-319, 2007 | 589 | 2007 |
| Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer CP Crum, R Drapkin, D Kindelberger, F Medeiros, A Miron, Y Lee Clinical medicine & research 5 (1), 35-44, 2007 | 451 | 2007 |
| Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention JW Carlson, A Miron, EA Jarboe, MM Parast, MS Hirsch, Y Lee, MG Muto, ... Journal of Clinical Oncology 26 (25), 4160-4165, 2008 | 437 | 2008 |
| Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups EM John, A Miron, G Gong, AI Phipps, A Felberg, FP Li, DW West, ... Jama 298 (24), 2869-2876, 2007 | 428 | 2007 |
| Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data X Zhang, X Lu, Q Shi, X Xu, HCE Leung, LN Harris, JD Iglehart, A Miron, ... BMC bioinformatics 7, 1-13, 2006 | 400 | 2006 |
| BRCA1 supports XIST RNA concentration on the inactive X chromosome S Ganesan, DP Silver, RA Greenberg, D Avni, R Drapkin, A Miron, ... Cell 111 (3), 393-405, 2002 | 385 | 2002 |
| Genome-wide association analysis identifies three new breast cancer susceptibility loci M Ghoussaini, O Fletcher, K Michailidou, C Turnbull, MK Schmidt, E Dicks, ... Nature genetics 44 (3), 312-318, 2012 | 380 | 2012 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 342 | 2013 |
| Serous carcinogenesis in the fallopian tube: a descriptive classification E Jarboe, A Folkins, MR Nucci, D Kindelberger, R Drapkin, A Miron, Y Lee, ... International Journal of Gynecological Pathology 27 (1), 1-9, 2008 | 334 | 2008 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 322 | 2015 |
| E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. J DeGregori, G Leone, K Ohtani, A Miron, JR Nevins Genes & development 9 (23), 2873-2887, 1995 | 289 | 1995 |
| Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers ZC Wang, M Lin, LJ Wei, C Li, A Miron, G Lodeiro, L Harris, ... Cancer research 64 (1), 64-71, 2004 | 277 | 2004 |
| Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance N Johnson, SF Johnson, W Yao, YC Li, YE Choi, AJ Bernhardy, Y Wang, ... Proceedings of the National Academy of Sciences 110 (42), 17041-17046, 2013 | 275 | 2013 |
